AHA Coding Clinic® for ICD-9 - 2007 Quarter 4; Volume 3 New/Revised Codes
Blood Brain Barrier
A 12-year-old patient was admitted to the hospital for chemotherapy due to recurrent CNS medulloblastoma involving both cerebral hemispheres and cerebellum. Prior to the administration of chemotherapy, he underwent blood brain barrier disruption. What code should be assigned as the principal diagnosis for this admission, a code for the malignancy or a code to show that the patient was admitted for chemotherapy? Also, what is the code for the blood brain barrier disruption? ...
Subscribe or sign in to view the full article.
Article Overview
This article covers an October 1, 2007 coding update for blood brain barrier disruption via infusion and explains the clinical context of intra-arterial chemotherapy delivery to the brain. It is intended for coders and revenue cycle professionals who need to understand the documentation context, associated code references, and the relationship between the barrier-disruption procedure and chemotherapy encounters.
Why This Topic Matters
Accurate reporting of this type of specialized infusion-based procedure depends on recognizing the relevant coding update and the surrounding chemotherapy admission context. The article helps readers determine whether an encounter is primarily for chemotherapy and how the blood brain barrier disruption is discussed in coding terms.
What You Will Learn
- The clinical purpose of blood brain barrier disruption in chemotherapy delivery
- The coding update associated with the procedure
- How the article frames the relationship between chemotherapy admission and the barrier-disruption procedure
- The hospital encounter context discussed in the example scenario
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Clinical documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com